Received Nov 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 1 | U7969AA | IM / RL |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | Y017513 | SC / RL |
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | UNK | U7969AA | LL |
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | UNK | — | — |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y017513 | RL |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | — |
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 1 | — | — |
Inadvertently administered an extra dose of Vaxelis; Off label use in 6-year-old; This non-serious spontaneous Safety Report was received with reference number: 02876687 (Interaction number: 02876686) by partner on 22-SEP-2025 and forwarded on 23-SEP-2025 from a Health Professional Due to the nature of the event, the causality between Vaxelis and the events of "Inadvertently administered an extra dose of Vaxelis" and "Off label use in 6-year-old" were not applicable. This case is considered off-label use. Further information is expected. SIGNFIICANT FOLLOW-UP INFORMATION for this non-serious spontaneous Safety Report was received from a healthcare professional on 07-OCT-2025 from a healthcare professional. Additional information for this case was received with reference number: 02876687 (Interaction number: 02876686) by partner on 07-OCT-2025 and forwarded on 08-OCT-2025 from a healthcare professional. Due to the nature of the event, the causality between Vaxelis and the events of "Inadvertently administered an extra dose of Vaxelis" and "Off label use in 6-year-old" were not applicable. This case is considered off-label use. Further information is not expected.
Prophylaxis
PROQUAD